Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy
Zhao, Di2,3; Jiang, Kai2; Wang, Yuqi2; Cheng, Jin2; Mo, Fangli2; Luo, Tao2; Guo, Yuanyuan1; Zhang, Chuan1; Song, Jie2,4
刊名ADVANCED HEALTHCARE MATERIALS
2021-01-12
关键词controllable esterase response high loading efficiency lung targeting multi-drug resistance universal drug encapsulation
ISSN号2192-2640
DOI10.1002/adhm.202001803
通讯作者Zhao, Di(zhaodi@sit.edu.cn) ; Song, Jie(sjie@sjtu.edu.cn)
英文摘要Most anticancer drugs, particularly paclitaxel (PTX), are suffering the challenges of cancer chemotherapy due to their poor water-solubility, high toxicity under effective therapeutic dosages, and multi-drug resistance. Currently, nanoscale drug delivery systems (DDSs) represent an efficient platform to overcome the above challenges. However, those DDSs generally need a careful design of conjugation, complexation, or co-self-assembly. Herein, a facile out-of-the-box nanocapsule is developed not only to be easily packed with on-demand hydrophobic anticancer drugs (up to 76% of loading efficiency for PTX), but also to be loaded with other concomitant drugs for synergy therapy (Itraconazole (ITA) here as P-glycoprotein inhibitor for drug resistance and antiangiogenic agent for combination therapy with PTX). Three kinds of biocompatible poly(ethylene glycol) dimethacrylates (PEGDM) derivatives usually as cross-linking agents are selected and successfully constructed adequate nanocapsules with single monomer as shell materials. More importantly, as-prepared nanocapsules have abilities of esterase triggering and lung targeting. Both in vitro and in vivo studies showed that the drug-loaded nanocapsules can effectively inhibit tumor growth and vascular proliferation in PTX-resistant tumor models without apparent systemic toxicity. The above results demonstrate that the nanocapsule system provides an effective and universal strategy for lung targeting, esterase triggering, and synergy therapy.
资助项目National Natural Science Foundation of China[81822024] ; National Natural Science Foundation of China[11761141006] ; Natural Science Foundation of Shanghai, China[19520714100] ; Natural Science Foundation of Shanghai, China[19ZR1475800] ; National Key Research and Development Program of China[2017YFC1200904] ; Medical Engineering Cross Project of Shanghai Jiaotong University[YG2017ZD07]
WOS关键词IN-VITRO ; CANCER ; DELIVERY ; NANOPARTICLES ; GROWTH ; ANGIOGENESIS ; ITRACONAZOLE ; CHEMOTHERAPY ; DOCETAXEL ; MECHANISM
WOS研究方向Engineering ; Science & Technology - Other Topics ; Materials Science
语种英语
出版者WILEY
WOS记录号WOS:000606896500001
资助机构National Natural Science Foundation of China ; Natural Science Foundation of Shanghai, China ; National Key Research and Development Program of China ; Medical Engineering Cross Project of Shanghai Jiaotong University
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/120077]  
专题中国科学院合肥物质科学研究院
通讯作者Zhao, Di; Song, Jie
作者单位1.Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Frontiers Sci Ctr Transformat Mol, State Key Lab Met Matrix Composites, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
2.Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Dept Instrument Sci & Engn, Inst Nano Biomed & Engn, Shanghai 200240, Peoples R China
3.Shanghai Inst Technol, Sch Perfume & Aroma Technol, Shanghai 201418, Peoples R China
4.Univ Chinese Acad Sci, Canc Hosp, Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou 310022, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Di,Jiang, Kai,Wang, Yuqi,et al. Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy[J]. ADVANCED HEALTHCARE MATERIALS,2021.
APA Zhao, Di.,Jiang, Kai.,Wang, Yuqi.,Cheng, Jin.,Mo, Fangli.,...&Song, Jie.(2021).Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy.ADVANCED HEALTHCARE MATERIALS.
MLA Zhao, Di,et al."Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy".ADVANCED HEALTHCARE MATERIALS (2021).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace